Belarus vs Georgia: The number of people with susceptibility test result for rifampicin
Belarus
1,032
in 2021
Georgia
953
in 2021
Belarus rank
66th
Georgia rank
68th
The number of people with susceptibility test result for rifampicin over time
- Belarus
- Georgia
How they compare
Belarus currently reports 1,032 against 953 in Georgia, a difference of 79.
That makes Belarus's figure about 1.1 times Georgia's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Belarus ahead.
Belarus ranks 66th and Georgia ranks 68th of 155 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,570 | 1,372 | 198 | Belarus |
| 2020s | 1,024 | 1,008 | 15 | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belarus or Georgia?
- Belarus, at 1,032 against 953 in Georgia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belarus and Georgia?
- 79, with Belarus ahead.
- How many years of comparable data are there for Belarus and Georgia?
- 5 years are reported by both, from 2017 to 2021.
- How do Belarus and Georgia rank globally for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 66th and Georgia ranks 68th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.